Singapore markets closed

NeuBase Therapeutics, Inc. (NBSE)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4336+0.0137 (+3.26%)
At close: 04:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
30/09/2022
30/09/2021
30/09/2020
Assets
Current assets
Cash
Cash and cash equivalents
23,153
52,893
31,992
Total cash
23,153
52,893
31,992
Other current assets
-
-
294.64
Total current assets
24,649
54,929
32,809
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
9,068
8,943
1,326
Accumulated depreciation
-1,296
-533.486
-158.666
Net property, plant and equipment
7,772
8,409
1,167
Equity and other investments
0
415.744
323.557
Other long-term assets
-
160.423
-
Total non-current assets
8,045
9,239
1,636
Total assets
32,693
64,168
34,444
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
148.385
138.557
Accounts payable
1,843
1,808
1,505
Accrued liabilities
857.794
836.319
311.491
Other current liabilities
-
-
950.151
Total current liabilities
4,166
4,194
3,150
Non-current liabilities
Total non-current liabilities
5,335
5,904
0
Total liabilities
9,502
10,098
3,150
Stockholders' equity
Common stock
3.3
3.272
2.315
Retained earnings
-102,744
-68,968
-43,559
Total stockholders' equity
23,192
54,070
31,295
Total liabilities and stockholders' equity
32,693
64,168
34,444